Abstract

Background: Central venous stenosis (CVS) is often found in patients on hemodialysis. Prior ipsilateral central venous catheterization and cardiac rhythm insertion are major risk factors, however the lack of this history may potentially lead to CVS. Chronic CVS may lead to thrombosis at the point of stenosis with partial or total blockage of the central vein. Objective: To assess in patency, complication rate and death rates the impact of the endovascular repair of central vein blockage following arteriovenous fistula formation. Methods and patients: This potential non-randomized research will be carried out at the Nasr Insurance hospitals vascular chirurgy department. The trial will involve 20 individuals with chronic renal disease and limb edoema after the development of fistula. In accordance with the inclusion criteria listed below, the Ethical Committee shall receive permission. Results: Only 11 patients had balloon angioplasty. There were no immediate difficulties. Six patients with restenosis. One in six patients with PTA with stenting had restenosis. One patient developed recurrence in the stent on diagnostic venography (stenosis). All recurring patients had repeat PTA. Conclusion: Endovascular therapy in individuals who are hemodialysed is an effective and safe approach for the treatment of CVD. Without severe morbidity or death, there is a high technical success rate. Multiple re-interventions for the treatment of restenosis are nonetheless necessary.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call